* | Page 1 | Search Results | Emerging Technologies and Data Science

1-20 of 21 Search Results for

*

Sort by

Sort Order Select

Journal Articles

Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors

Tharani Krishnan, Joao Paulo Solar Vasconcelos, Emma Titmuss, Robert J. Vanner, David F. Schaeffer, Aly Karsan, Howard Lim, Cheryl Ho, Sharlene Gill, Stephen Yip, Stephen K. Chia, Hagen F. Kennecke, Derek J. Jonker, Eric X. Chen, Daniel J. Renouf, Chris J. O’Callaghan, Jonathan M. Loree

Cancer Research Communications (2025) 5 (1): 66–73.

https://doi.org/10.1158/2767-9764.CRC-24-0522

Published: 09 January 2025

View article titled, Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors

Includes: Supplementary data

Journal Articles

Serially quantifying TERT rearrangement breakpoints in circulating tumor DNA enables minimal residual disease monitoring in patients with neuroblastoma

Cancer Research Communications (2025)

https://doi.org/10.1158/2767-9764.CRC-24-0569

Published: 06 January 2025

View article titled, Serially quantifying TERT rearrangement breakpoints in circulating tumor DNA enables minimal residual disease monitoring in patients with neuroblastoma

Includes: Supplementary data

Journal Articles

A cost-effective two-step approach for multi-cancer early detection in high-risk populations

Shuaipeng Geng, Shiyong Li, Wei Wu, Yinyin Chang, Mao Mao

Cancer Research Communications (2024)

https://doi.org/10.1158/2767-9764.CRC-24-0508

Published: 31 December 2024

View article titled, A cost-effective two-step approach for multi-cancer early detection in high-risk populations

Includes: Supplementary data

Journal Articles

Identification of ncRNA Biomarkers in Non–Small Cell Lung Cancer to Address Racial Disparities

Lu Gao, Pushpa Dhilipkannah, Feng Jiang

Cancer Research Communications (2024) 4 (12): 3201–3208.

https://doi.org/10.1158/2767-9764.CRC-24-0262

Published: 27 December 2024

View article titled, Identification of ncRNA Biomarkers in Non–Small Cell Lung Cancer to Address Racial Disparities

Includes: Supplementary data

Journal Articles

The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma

Carolina Giordano, Laura Marrone, Simona Romano, Giuseppe Maria Della Pepa, Carlo Maria Donzelli, Martina Tufano, Mario Capasso, Vito Alessandro Lasorsa, Cristina Quintavalle, Giulia Guerri, Matia Martucci, Annamaria Auricchio, Marco Gessi, Evis Sala, Alessandro Olivi, Maria Fiammetta Romano, Simona Gaudino

Cancer Research Communications (2024) 4 (5): 1296–1306.

https://doi.org/10.1158/2767-9764.CRC-24-0083

Published: 16 May 2024

View article titled, The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma

Includes: Supplementary data

Journal Articles

Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer

Cancer Research Communications (2023) 3 (11): 2221–2232.

https://doi.org/10.1158/2767-9764.CRC-23-0175

Published: 03 November 2023

View article titled, Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer

Includes: Supplementary data

Journal Articles

Serum Free Fatty Acid Changes Caused by High Expression of Stearoyl-CoA Desaturase 1 in Tumor Tissues Are Early Diagnostic Markers for Ovarian Cancer

Kanoko Katoh, Yuki Katoh, Akiko Kubo, Miho Iida, Yuji Ikeda, Takashi Iwata, Hiroshi Nishio, Masaki Sugawara, Daiki Kato, Makoto Suematsu, Shuichi Hirai, Kei Kawana

Cancer Research Communications (2023) 3 (9): 1840–1852.

https://doi.org/10.1158/2767-9764.CRC-23-0138

Published: 13 September 2023

View article titled, Serum Free Fatty Acid Changes Caused by High Expression of Stearoyl-CoA Desaturase 1 in Tumor Tissues Are Early Diagnostic Markers for Ovarian Cancer

Includes: Supplementary data

Journal Articles

Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics

Siwei Wang, Zhijun Xia, Jing You, Xiaolan Gu, Fanchen Meng, Peng Chen, Wanxiangfu Tang, Hua Bao, Jingyuan Zhang, Xue Wu, Yang Shao, Jie Wang, Xianglin Zuo, Lin Xu, Rong Yin

Cancer Research Communications (2023) 3 (5): 933–942.

https://doi.org/10.1158/2767-9764.CRC-22-0363

Published: 30 May 2023

View article titled, Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics

Includes: Supplementary data

Journal Articles

Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors

Boyang Sun, Tian Qiu, Xiaoling Zeng, Jianchun Duan, Hua Bai, Jiachen Xu, Jin Li, Junling Li, Xuezhi Hao, Yutao Liu, Lin Lin, Hongyu Wang, Xin Zhang, Jia Zhong, Jie Wang, Jianming Ying, Zhijie Wang

Cancer Research Communications (2023) 3 (4): 532–539.

https://doi.org/10.1158/2767-9764.CRC-22-0438

Published: 04 April 2023

View article titled, Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors

Includes: Supplementary data

Journal Articles

Predictive and Prognostic Implications of Circulating CX3CR1⁺ CD8⁺ T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy

Eihab Abdelfatah, Mark D. Long, Ryutaro Kajihara, Takaaki Oba, Takayoshi Yamauchi, Hongbin Chen, Joy Sarkar, Kristopher Attwood, Junko Matsuzaki, Brahm H. Segal, Grace K. Dy, Fumito Ito

Cancer Research Communications (2023) 3 (3): 510–520.

https://doi.org/10.1158/2767-9764.CRC-22-0383

Published: 30 March 2023

View article titled, Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy

Includes: Supplementary data

Journal Articles

Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma

Shaaron Ochoa-Rios, Calvin R.K. Blaschke, Mengjun Wang, Kendell D. Peterson, Andrew DelaCourt, Stéphane Elie Grauzam, David Lewin, Peggi Angel, Lewis R. Roberts, Richard Drake, Anand S. Mehta

Cancer Research Communications (2023) 3 (3): 383–394.

https://doi.org/10.1158/2767-9764.CRC-22-0422

Published: 06 March 2023

View article titled, Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma

Includes: Supplementary data

Journal Articles

Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

Derek Wong, Ping Luo, Nadia Znassi, Diana P. Arteaga, Diana Gray, Arnavaz Danesh, Ming Han, Eric Y. Zhao, Stephanie Pedersen, Stephenie Prokopec, Yogi Sundaravadanam, Dax Torti, Kayla Marsh, Sareh Keshavarzi, Wei Xu, Hatem Krema, Anthony M. Joshua, Marcus O. Butler, Trevor J. Pugh

Cancer Research Communications (2023) 3 (2): 267–280.

https://doi.org/10.1158/2767-9764.CRC-22-0456

Published: 15 February 2023

View article titled, Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

Includes: Supplementary data

Journal Articles

Complex Patterns of Genomic Heterogeneity Identified in 42 Tumor Samples and ctDNA of a Pulmonary Atypical Carcinoid Patient

Tamsin J. Robb, Peter Tsai, Sandra Fitzgerald, Paula Shields, Pascalene S. Houseman, Rachna Patel, Vicky Fan, Ben Curran, Rexson Tse, Jacklyn Ting, Nicole Kramer, Braden J. Woodhouse, Esther Coats, Polona Le Quesne Stabej, Jane Reeve, Kate Parker, Ben Lawrence, Cherie Blenkiron, Cristin G. Print

Cancer Research Communications (2023) 3 (1): 31–42.

https://doi.org/10.1158/2767-9764.CRC-22-0101

Published: 10 January 2023

View article titled, Complex Patterns of Genomic Heterogeneity Identified in 42 Tumor Samples and ctDNA of a Pulmonary Atypical Carcinoid Patient

Includes: Supplementary data

Journal Articles

The RPL/RPS Gene Signature of Melanoma CTCs Associates with Brain Metastasis

Tetiana Y. Bowley, Irina V. Lagutina, Carol Francis, Sinduja Sivakumar, Reed G. Selwyn, Erik Taylor, Yan Guo, Bridget N. Fahy, Bernard Tawfik, Dario Marchetti

Cancer Research Communications (2022) 2 (11): 1436–1448.

https://doi.org/10.1158/2767-9764.CRC-22-0337

Published: 16 November 2022

View article titled, The RPL/RPS Gene Signature of Melanoma CTCs Associates with Brain Metastasis

Includes: Supplementary data

Journal Articles

Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis

Laura E. Kane, Gregory S. Mellotte, Eimear Mylod, Rebecca M. O'Brien, Fiona O'Connell, Croí E. Buckley, Jennifer Arlow, Khanh Nguyen, David Mockler, Aidan D. Meade, Barbara M. Ryan, Stephen G. Maher

Cancer Research Communications (2022) 2 (10): 1229–1243.

https://doi.org/10.1158/2767-9764.CRC-22-0190

Published: 20 October 2022

View article titled, Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis

Includes: Supplementary data

Journal Articles

Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non–small Cell Lung Cancer

Malene S. Frank, Christina S.A. Andersen, Lise B. Ahlborn, Niels Pallisgaard, Uffe Bodtger, Julie Gehl

Cancer Research Communications (2022) 2 (10): 1174–1187.

https://doi.org/10.1158/2767-9764.CRC-22-0258

Published: 13 October 2022

View article titled, Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non–small Cell Lung Cancer

Includes: Supplementary data

Journal Articles

Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

Cancer Research Communications (2022) 2 (9): 979–986.

https://doi.org/10.1158/2767-9764.CRC-22-0194

Published: 14 September 2022

View article titled, Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

Includes: Supplementary data

Journal Articles

Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer

Cancer Research Communications (2022) 2 (6): 391–401.

https://doi.org/10.1158/2767-9764.CRC-22-0133

Published: 01 June 2022

View article titled, Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer

Includes: Supplementary data

Journal Articles

Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer

Margaret L. Axelrod, Yu Wang, Yaomin Xu, Xiaopeng Sun, Cosmin A. Bejan, Paula I. Gonzalez-Ericsson, Sara Nunnery, Riley E. Bergman, Joshua Donaldson, Angel L. Guerrero-Zotano, Chiara Massa, Barbara Seliger, Melinda Sanders, Ingrid A. Mayer, Justin M. Balko

Cancer Research Communications (2022) 2 (5): 286–292.

https://doi.org/10.1158/2767-9764.CRC-22-0023

Published: 04 May 2022

View article titled, Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer

Includes: Supplementary data

Journal Articles

Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors

Ana M. Metelo, Agnieszka Jozwik, Le Anh Luong, Delaney Dominey-Foy, Charlotte Graham, Charlotte Attwood, Shafqat Inam, Alan Dunlop, Katy Sanchez, Kirsty Cuthill, Carmel Rice, Matthew Streetly, Trevor Bentley, Bijan Boldajipour, Cesar Sommer, Barbra Sasu, Reuben Benjamin

Cancer Research Communications (2022) 2 (3): 158–171.

https://doi.org/10.1158/2767-9764.CRC-21-0157

Published: 23 March 2022

View article titled, Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors

NARROW

*

Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors

Serially quantifying TERT rearrangement breakpoints in circulating tumor DNA enables minimal residual disease monitoring in patients with neuroblastoma

A cost-effective two-step approach for multi-cancer early detection in high-risk populations

Identification of ncRNA Biomarkers in Non–Small Cell Lung Cancer to Address Racial Disparities

The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma

Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer

Serum Free Fatty Acid Changes Caused by High Expression of Stearoyl-CoA Desaturase 1 in Tumor Tissues Are Early Diagnostic Markers for Ovarian Cancer

Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics

Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors

Predictive and Prognostic Implications of Circulating CX3CR1⁺ CD8⁺ T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy

Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma

Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma

Complex Patterns of Genomic Heterogeneity Identified in 42 Tumor Samples and ctDNA of a Pulmonary Atypical Carcinoid Patient

The RPL/RPS Gene Signature of Melanoma CTCs Associates with Brain Metastasis

Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis

Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non–small Cell Lung Cancer

Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer

Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer

Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors

AACR Journals

*

AACR Journals

This Feature Is Available To Subscribers Only